Cardio-Kidney-Metabolic Disorder, An Issue of Cardiology Clinics
- 1 Edición, Volumen 43-3 - 7 de julio de 2025
- Última edición
- Editores: Silvi Shah, Janani Rangaswami
- Idioma: Inglés
In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder.… Leer más
In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.
- Contains 12 relevant, practice-oriented topics including atherosclerotic cardiovascular disease in CKM syndrome; kidney transplant and CKM health; pregnancy and CKM Health; nutrition and CKM health; CKM health in pediatrics and primordial prevention; and more
- Provides in-depth clinical reviews on cardio-kidney-metabolic disorder, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Cardiology
Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations
Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease
Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease
Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
Atherosclerotic Cardiovascular Disease in Cardiovascular–Kidney-Metabolic Syndrome
Kidney Transplant and Cardiovascular-Kidney-Metabolic Health
Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia
A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome
Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease
Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease
Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease
Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
Atherosclerotic Cardiovascular Disease in Cardiovascular–Kidney-Metabolic Syndrome
Kidney Transplant and Cardiovascular-Kidney-Metabolic Health
Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia
A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome
Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease
- Edición: 1
- Última edición
- Volumen: 43-3
- Publicado: 4 de agosto de 2025
- Idioma: Inglés
SS
Silvi Shah
Afiliaciones y experiencia
University of Cincinnati, USAJR
Janani Rangaswami
Afiliaciones y experiencia
George Washington University Hospital, Washington, DC, USA